Transcatheter aortic valve implantation in acute decompensated aortic stenosis.
Kush P PatelChris BroydOmar ChehabMelanie JerrumHelen QueenanKerry BedfordFahed BarakatSimon KennonMuhiddin OzkorAnthony MathurMichael J MullenPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
TAVI for ADAS is safe and effective with procedural outcomes similar to elective patients. However, compared to elective patients, they have worse physiological baseline features, poorer prognosis at 30 days, and longer hospital admissions. Majority of patients who presented with ADAS were known to have AS prior to admission.
Keyphrases
- ejection fraction
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- aortic valve
- transcatheter aortic valve replacement
- end stage renal disease
- newly diagnosed
- heart failure
- emergency department
- left ventricular
- patients undergoing
- prognostic factors
- liver failure
- type diabetes
- skeletal muscle
- drug induced
- respiratory failure
- mechanical ventilation